Novel Drug 2017- New
Drug Name:Novel Drug 2017- New
List Of Brands:
Indication Type Description:
Indication
Indication:
Novel Drug/New Approvals for 2016-New
(For more salient details please refer the Drug)
No. Drug Name Active Ingred. Apprvl Date FDA Approved use on approved date
M- Manufacturer D- Distributor
1.TRULANE Plecanatide Feb 2017
2.PARSALBIV Etelcacenatide Feb 2017
3.EMFLAZA Deflazocort Feb 2017
4.SILIQ Brodalumab Feb 2017
5.XERMELO Telotristat Feb 2017
6.KIQUALI Ribociclib Mar 2017
7.XADAGO Avelumab Mar 17 Metastatic Merkel cell carcinoma (MRC)
8.BAVENCIO Avelumab Mar 2017
9.SYNPROIC Nardemedine Mar 2017
10.ZEJULA Niraparib Mar 2017
11.DUPIXENT Dupilumab Mar 2017
12. OCTREVUS Ocrielizumab Mar 2017
13.AUSTEDO Deutetrabenazine April 2017
14. INGRESSA Vazbemazine April 2017
15. BRINEURA Cerliponase April 2017
16.ALUNBRIG Brigatinib April 2017
17.RYDAPT Midastavrin April 2017
18.TYMLOS Abaloparatide April 2017
19.IMFINZI Duravalumab May 2017
20.RDICAVA Edaravone May 2017
21.KEVZARA Sarilvmab May 2017
22..BAXDELA Delfloxacin June 2017
23.BEVYXXA Betrixaban June 2017
24. TREMYA Guselkumab July 2017
25.NERLYNX Neratinib July 2017
26. VOSEVI Sofosbuvir July 2017
27. INHIFA Enasidenib August 2017
28.MAVRET Glecaprevir August 2017
29.BEPONSA Inotuzmab August 2017
30. VOBOMERE Meropenam August 2017
31.BENZNIDAZOLE Benznidazole August 2017
32.ALIQUOPA Copanlisib September 2017
33.SOLOSEC Secnidazole September 2017
34. VERZENIO Abemaciclib Sepember 2017
35. CALQUENCE Aclabrutinib October 2017
36. VYZULTA Latanoprostene Novemvber 2017
37.PREVYMIS Letetmovir November 2017
38.FASENRA Benralizmab November 2017
39.MESEVII Vestronidase alfa November 2017
40. HEMLIBRA Emicizumab November 2017
41. OZEMPIC Semaglutide December 2017
42.XEPI Ozenoxacin December 2017
43. RHOPRESSA Netrasudil December 2017
44. STEGLATRO Ertugliflozin December 2017
45.MACRILEN Macimorelin December 2017
46. GLAPREZA Anliotensin 11 December 2017
